Legal Opinion
Pharmacia & Upjohn Co. v. Mylan Pharmaceuticals, Inc.
District Court, N.D. West Virginia
Decided March 31, 1998No. 3:97-cv-00041PublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
BROADWATER, District Judge.
I. INTRODUCTION
This is a patent infringement action in which plaintiff, Pharmacia & Upjohn Company (Upjohn), alleges that defendant, Mylan Pharmaceuticals Inc. (Mylan), has infringed Upjohn’s United States patent 4,916,163 (the ’163 patent) relating to certain pharmaceutical formulations of the anti-diabetic drug, glyburide. The action arises in part out of the Drug Price Competition and Patent Term Restoration Act of 1984, P.L. 98-417, 21 U.S.C. § 355(j) and 35 U.S.C. § 271(e) (commonly referred to as the “Wax-man-Hatch Act”). Upjohn…
2Cases cited23 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Blonder-Tongue Laboratories, Inc. v. University of Illinois FoundationSupreme Court of the United States · 1971
- Cohens v. VirginiaSupreme Court of the United States · 1821
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
18 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Pharmacia & Upjohn Company v. Mylan Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 1999
- Pharmacia & Upjohn Company v. Mylan Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 1999
- Merck & Co., Inc. v. Mylan Pharmaceuticals, Inc.District Court, E.D. Pennsylvania · 1998
- Glaxo Wellcome, Inc. v. Impax Laboratories, Inc.District Court, N.D. California · 2002
- Abbott Laboratories v. Mylan Pharmaceuticals, Inc.District Court, N.D. Illinois · 1999